Myeloid and lymphoid neoplasm with novel complex translocation: unusual case report with T-lymphoblastic lymphoma, myeloid hyperplasia, eosinophilia, basophilia, and t(1;8;10)( (p31;q24;q11.2).
Mansour S AljabryPublished in: Journal of hematopathology (2022)
Myeloid and lymphoid neoplasms with eosinophilia (M/Ls-Eo) encompass heterogeneous but aggressive hematopoietic disorders triggered by fusion genes or mutations that typically lead to constitutive overexpression of tyrosine kinase. The occurrence of T-lymphoblastic lymphoma in the setting of M/Ls-Eo has been reported rarely in the literature. Herein, we present an unusual case of a 28-year-old male patient who presented with massive lymphadenopathy and T-lymphoblastic lymphoma in the lymph node occurring concurrently with myeloid hyperplasia, eosinophilia and basophilia in peripheral blood and bone marrow biopsy. The syndrome was associated with a novel complex karyotype involving der(8)t(1;8;10)(p31;q24;q11.2). The FISH study was negative for BCR::ABL1, JAK2, PDGFRA, PDGFRB, and FGFR1 rearrangements. The patient's clinical course was aggressive and resistant to multiple lines of intensive chemotherapy regimens. Therefore, he underwent allogenic stem cell transplantation with a fully matched donor. A brief review of the occurrence of T-LBL in conjunction with M/Ls-Eo neoplasm was made with a special focus on molecular aspects.
Keyphrases
- bone marrow
- tyrosine kinase
- case report
- stem cell transplantation
- lymph node
- diffuse large b cell lymphoma
- epidermal growth factor receptor
- dendritic cells
- peripheral blood
- acute myeloid leukemia
- mesenchymal stem cells
- risk assessment
- high dose
- systematic review
- low grade
- cell proliferation
- chronic myeloid leukemia
- locally advanced
- acute lymphoblastic leukemia
- ultrasound guided
- transcription factor
- fine needle aspiration
- radiation therapy
- immune response
- chemotherapy induced
- genome wide analysis